GlassScriptPhysician profile
Quan Minh Lam
NPI 1174240535
$1,180.28
in general payments reported to CMS, 2019-2025
11 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $254 · 2024: $460 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.28 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $298.67 | 2024-2025 | Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.98 | 2023-2025 | Xifaxan, Trulance |
| Abbvie INC. | $173.60 | 2023-2025 | |
| Novo Nordisk INC | $116.11 | 2023-2025 | Wegovy |
| Impel Pharmaceuticals INC. | $89.10 | 2023 | Trudhesa |
| Exact Sciences Corporation | $79.36 | 2023-2025 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $70.29 | 2023-2024 | Contrave, Nexletol |
| Axsome Therapeutics, INC. | $32.28 | 2025 | Symbravo |
| Amgen INC. | $20.83 | 2024 | Otezla, Repatha |
| Inari Medical, INC. | $20.13 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $18.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quan Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.